文献速递心胸血管麻醉

七氟烷对心脏瓣膜手术患者血管内皮糖萼的保护作用:一项随机对照试验

Protective effect of sevoflurane on vascular endothelial glycocalyx in patients undergoing heart valve surgery: A randomised controlled trial.
PubMed 文献 · Eur J Anaesthesiol · 2021-01-01

结果显示七氟烷组糖萼损伤程度较轻,尿白蛋白/肌酐比值更低,术后乳酸和心肌酶水平更低,机械通气时间更短。结论认为七氟烷可减轻体外循环下心脏瓣膜手术患者的糖萼降解。

要点

  • 七氟烷麻醉可减轻体外循环期间血管内皮糖萼的降解。
  • 七氟烷组尿白蛋白/肌酐比值低于丙泊酚组。
  • 七氟烷组术后乳酸和心肌酶水平更低,机械通气时间更短。

核心结论

  • 七氟烷可减轻体外循环下心脏瓣膜手术患者的血管内皮糖萼降解。

主要发现

  • 体外循环期间血管内皮糖萼发生损伤,七氟烷组的糖萼损伤程度轻于丙泊酚组。
  • 两组尿白蛋白/肌酐比值均升高,但七氟烷组较低。
  • 基质金属蛋白酶-9和cathepsin-B与糖萼标志物浓度呈正相关。
  • 术后七氟烷组乳酸和心肌酶水平低于丙泊酚组,术后机械通气时间短于丙泊酚组。

临床怎么用

  • 在心脏瓣膜手术体外循环期间,可考虑选用七氟烷麻醉以减轻血管内皮糖萼损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The glycocalyx plays an important physiological role and may be damaged during cardiopulmonary bypass. Sevoflurane can protect the glycocalyx; however, its relevance in a clinical setting is unknown. OBJECTIVE: Glycocalyx degradation during cardiopulmonary bypass in patients was investigated. On the basis of the available experimental data, we hypothesised that sevoflurane-based anaesthesia would confer additional protection against cardiopulmonary bypass-induced glycocalyx damage. DESIGN: Randomised controlled study. SETTING: Clinical study at The First Affiliated Hospital of Wenzhou Medical University between June 2018 and March 2019. PATIENTS: Fifty-one patients. INTERVENTIONS: After intubation and mechanical ventilation, patients undergoing elective heart valve surgery were maintained under general anaesthesia with either propofol or sevoflurane during surgery. MAIN OUTCOME MEASURES: Glycocalyx markers (such as syndecan-1, heparan sulphate and hyaluronan), sheddases responsible for the degradation of the endothelial glycocalyx (such as matrix metalloproteinase-9 and cathepsin-B), urine albumin-to-creatinine ratio and levels of lactic acid and myocardial enzymes were all measured. Postoperative mechanical ventilation time and length of stay in the cardiac care unit and hospital were also measured. Morbidity and mortality after 30 days and 1 year were evaluated. RESULTS: The vascular endothelial glycocalyx was damaged during cardiopulmonary bypass. The glycocalyx damage in the sevoflurane group was less extensive than that in the propofol group. The urine albumin-to-creatinine ratio increased in both groups but was lower in the sevoflurane group. Enzymes including matrix metalloproteinase-9 and cathepsin-B were positively correlated with glycocalyx marker concentrations. After operation, the sevoflurane group showed lower levels of lactic acid and myocardial enzyme, as well as shorter duration of postoperative mechanical ventilation than the propofol group. CONCLUSION: Sevoflurane can decrease glycocalyx degradation in patients undergoing heart valve surgery under cardiopulmonary bypass. TRIAL REGISTRATION: Chinese Clinical Trial Registry, chictr.org.cn, identifier: ChiCTR1800016367.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Fang FQ, Sun JH, Wu QL, et al. Protective effect of sevoflurane on vascular endothelial glycocalyx in patients undergoing heart valve surgery: A randomised controlled trial. Eur J Anaesthesiol. 2021. PMID: 33399382. doi:10.1097/EJA.0000000000001429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。